3191 results for «973»
3191 results
Transcatheter mitral valve therapies beyond TEER
17 May 2023 – From EuroPCR 2023
Take a ride into the realm of transcatheter mitral valve therapy, going beyond the limits of TEER. Discover the captivating complexities and innovative strategies in this dynamic field, starting with a compelling initial case: transcatheter mitral valve replacement (TMVR) utilizing a semi-rigid flexible three-dimensional annuloplasty ring.
Tricuspid and pulmonary valves: the right heart in trouble
18 May 2023 – From EuroPCR 2023
Explore the intricacies of tricuspid and pulmonary valve disorders, as we delve into the challenges faced by the right heart in this session: discover the groundbreaking approach of triple percutaneous valvular therapy in patient with congenital heart disease, learn about innovative strategies for managing massive atrial...
Challenging PCI in patients with complex coronary anatomy
17 May 2023 – From EuroPCR 2023
View complex cases including multivessel complex PCI using distal radial access in ACS and cardiogenic shock, complex SVG PCI, LM dissection in CHIP, and even more!
CTO complications
18 May 2023 – From EuroPCR 2023
Navigate through the world of complex chronic total occlusion (CTO) interventions and explore the challenging complications that may arise in this session: encounter a rare case involving simultaneous septal rupture and donor vessel thrombosis during a retrograde CTO procedure, learn about the management strategies for distal...
Changes of STEMI in young patients
17 May 2023 – From EuroPCR 2023
This session will enable you to gain knowledge about "Changes in ST-segment elevation myocardial infarction (STEMI) in young patients" and explore the implications for diagnosis and treatment through a series of challenging real-life case presentations.
PCR STATEMENT on the 2-year clinical outcomes from the Evolut low risk trial
18 May 2021
Transcatheter aortic valve implantation (TAVI) offers an effective, less invasive therapeutic alternative to surgical aortic valve replacement in patients with symptomatic, severe aortic stenosis. Although TAVI is demonstrated to be superior to medical therapy or surgery in patients who are at prohibitive or high risk for...
TRI.fr trial - Multicentric randomised evaluation of the transcatheter edge-to-edge repair in the treatment of severe isolated secondary tricuspid regurgitation
31 Aug 2024
Alex Sticchi provides his take on the results of the TRI.FR trial presented by Erwan Donal at the ESC Congress 2024 in London.
Author
EuroPCR 2024 – One-month DAPT followed by 5-month Ticagrelor monotherapy in acute coronary syndromes with DCB - results from REC-CAGEFREE II
15 May 2024
Paris, France, 14-17 May 2024. The Course Directors have selected 3 major Late Breaking Trials (LBTs) that will be presented for the first time during the 2024 edition of EuroPCR. These trials were selected on account of their design, outcomes and potential to influence daily clinical...
30 years of primary PCI – a tale of perseverance
16 May 2023
Over the last 30 years, primary PCI (pPCI) has evolved from an experimental ‘rescue’ intervention to an essential routine procedure – performed daily in cathlabs around the world – which is responsible for saving millions of lives. However, its path to success was far from smooth.
Transcatheter vs surgical aortic valve replacement in aortic stenosis patients at low surgical risk: 3-year outcomes from the Evolut Low Risk trial
05 Mar 2023
Luigi Biasco provides his take on the clinical trial presented by John K. Forrest from Yale University School of Medicine, New Haven, Connecticut, USA during the 2023 ACC/WCC annual congress held in New Orleans, Louisiana.
Author
Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes: The multicenter, randomized, blinded, IVUS-ACS Trial
09 Apr 2024
Marco Spagnolo and Daniele Giacoppo report the main results of the IVUS-ACS trial presented by Shao-Liang Chen, from the Nanjing First Hospital, Nanjing Medical University, Nanjing, in a Featured Clinical Research session at ACC.24 in Atlanta and simultaneously published in The Lancet.(1)
Author
Author
